Genetic Testing for Personalized Tirzepatide Response The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
2022;28(suppl 15):S288-S296
Using these numbers, we were able to calculate that the Relative Risk of GLP-1 RA exposure was 0.69 and the Odds Ratio of GLP-1 RA exposure was 0.67
Long-Term Considerations and Maintenance Although these procedures can offer significant improvements, it is important to remember that maintaining your results will require ongoing care
Left untreated, fibroids will likely persist or grow, which can lead to long-term complications
Our comprehensive program includes expert clinician consultations, personalized prescriptions, dedicated coaching, and essential lab work (if you haven't completed the required tests within the last 12 months)